ANI Pharmaceuticals (ANIP)

[rgshredder]

Zacks bot article came out just now:

One company to watch right now is ANI Pharmaceuticals (ANIP - Free Report) . ANIP is currently sporting a Zacks Rank of #2 (Buy) and an A for Value.

We should also highlight that ANIP has a P/B ratio of 2.39. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 3.80. Over the past year, ANIP's P/B has been as high as 4.97 and as low as 1.73, with a median of 3.81.

Finally, investors will want to recognize that ANIP has a P/CF ratio of 9.85. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. This stock's P/CF looks attractive against its industry's average P/CF of 11.64. Over the past 52 weeks, ANIP's P/CF has been as high as 17.56 and as low as 7.11, with a median of 14.40.

These are only a few of the key metrics included in ANI Pharmaceuticals's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, ANIP looks like an impressive value stock at the moment.

-RG